Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
Abstract Endothelin-1 (ET-1) is involved in the pathogenesis of cardiac and renal diseases, and in the progression of tumour growth in cancer, but current diagnosis and treatment remain inadequate. Peptides derived from the 212 amino acid precursor preproendothelin-1 (ppET-1) may have utility as bio...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c88405d4ef9a4272ab9b01473d274a6f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c88405d4ef9a4272ab9b01473d274a6f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c88405d4ef9a4272ab9b01473d274a6f2021-12-02T15:18:52ZCharacterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-110.1038/s41598-017-05365-22045-2322https://doaj.org/article/c88405d4ef9a4272ab9b01473d274a6f2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05365-2https://doaj.org/toc/2045-2322Abstract Endothelin-1 (ET-1) is involved in the pathogenesis of cardiac and renal diseases, and in the progression of tumour growth in cancer, but current diagnosis and treatment remain inadequate. Peptides derived from the 212 amino acid precursor preproendothelin-1 (ppET-1) may have utility as biomarkers, or cause biological effects that are unaffected by endothelin receptor antagonists. Here, we used specific immunoassays and LC-MS/MS to identify NT-proET-1 (ppET-1[18–50]), Endothelin-Like Domain Peptide (ELDP, ppET-1[93–166]) and CT-proET-1 (ppET-1[169–212]) in conditioned media from cultured endothelial cells. Synthesis of these peptides correlated with ET-1, and plasma ELDP and CT-proET-1 were elevated in patients with chronic heart failure. Clearance rates of NT-proET-1, ELDP and CT-proET-1 were determined after i.v. injection in anaesthetised rats. CT-proET-1 had the slowest systemic clearance, hence providing a biological basis for it being a better biomarker of ET-1 synthesis. ELDP contains the evolutionary conserved endothelin-like domain sequence, which potentially confers biological activity. On isolated arteries ELDP lacked direct vasoconstrictor effects. However, it enhanced ET-1 vasoconstriction and prolonged the increase in blood pressure in anaesthetised rats. ELDP may therefore contribute to disease pathogenesis by augmenting ET-1 responses.Jale YuzugulenJulie A. DouthwaiteElizabeth G. WoodInmaculada C. VillarNimesh S. A. PatelJames JegardHubert GaertnerIrène Rossitto-BorlatKeith RoseOliver HartleyPedro R. CutillasAmrita AhluwaliaRoger CorderNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Jale Yuzugulen Julie A. Douthwaite Elizabeth G. Wood Inmaculada C. Villar Nimesh S. A. Patel James Jegard Hubert Gaertner Irène Rossitto-Borlat Keith Rose Oliver Hartley Pedro R. Cutillas Amrita Ahluwalia Roger Corder Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 |
description |
Abstract Endothelin-1 (ET-1) is involved in the pathogenesis of cardiac and renal diseases, and in the progression of tumour growth in cancer, but current diagnosis and treatment remain inadequate. Peptides derived from the 212 amino acid precursor preproendothelin-1 (ppET-1) may have utility as biomarkers, or cause biological effects that are unaffected by endothelin receptor antagonists. Here, we used specific immunoassays and LC-MS/MS to identify NT-proET-1 (ppET-1[18–50]), Endothelin-Like Domain Peptide (ELDP, ppET-1[93–166]) and CT-proET-1 (ppET-1[169–212]) in conditioned media from cultured endothelial cells. Synthesis of these peptides correlated with ET-1, and plasma ELDP and CT-proET-1 were elevated in patients with chronic heart failure. Clearance rates of NT-proET-1, ELDP and CT-proET-1 were determined after i.v. injection in anaesthetised rats. CT-proET-1 had the slowest systemic clearance, hence providing a biological basis for it being a better biomarker of ET-1 synthesis. ELDP contains the evolutionary conserved endothelin-like domain sequence, which potentially confers biological activity. On isolated arteries ELDP lacked direct vasoconstrictor effects. However, it enhanced ET-1 vasoconstriction and prolonged the increase in blood pressure in anaesthetised rats. ELDP may therefore contribute to disease pathogenesis by augmenting ET-1 responses. |
format |
article |
author |
Jale Yuzugulen Julie A. Douthwaite Elizabeth G. Wood Inmaculada C. Villar Nimesh S. A. Patel James Jegard Hubert Gaertner Irène Rossitto-Borlat Keith Rose Oliver Hartley Pedro R. Cutillas Amrita Ahluwalia Roger Corder |
author_facet |
Jale Yuzugulen Julie A. Douthwaite Elizabeth G. Wood Inmaculada C. Villar Nimesh S. A. Patel James Jegard Hubert Gaertner Irène Rossitto-Borlat Keith Rose Oliver Hartley Pedro R. Cutillas Amrita Ahluwalia Roger Corder |
author_sort |
Jale Yuzugulen |
title |
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 |
title_short |
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 |
title_full |
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 |
title_fullStr |
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 |
title_full_unstemmed |
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1 |
title_sort |
characterisation of preproendothelin-1 derived peptides identifies endothelin-like domain peptide as a modulator of endothelin-1 |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/c88405d4ef9a4272ab9b01473d274a6f |
work_keys_str_mv |
AT jaleyuzugulen characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT julieadouthwaite characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT elizabethgwood characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT inmaculadacvillar characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT nimeshsapatel characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT jamesjegard characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT hubertgaertner characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT irenerossittoborlat characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT keithrose characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT oliverhartley characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT pedrorcutillas characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT amritaahluwalia characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 AT rogercorder characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1 |
_version_ |
1718387474752864256 |